Atlas Trials

A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057

Clinical trial NCT02916537 · COMPLETED

Trial details

NCT number
NCT02916537
Sponsor
Cancer Targeted Technology
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2016-09-01
Primary completion
2017-08-28
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.